Английская Википедия:Bifemelane

Материал из Онлайн справочника
Версия от 05:22, 9 февраля 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|Antidepressant and cerebral activator drug}} {{Drugbox | Verifiedfields = changed | verifiedrevid = 459721492 | IUPAC_name = ''N''-methyl-4-[2-(phenylmethyl)phenoxy]butan-1-amine | image = Bifemelane.svg | width = 235 <!--Clinical data--> | tradename = Alnert, Celeport | Drugs.com = {{drugs.com|international|bifemelane}} | routes_of_administration = <!--Identifier...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

Bifemelane (INN) (Alnert, Celeport), or bifemelane hydrochloride (JAN), also known as 4-(O-benzylphenoxy)-N-methylbutylamine, is an antidepressant and cerebral activator that is widely used in the treatment of cerebral infarction patients with depressive symptoms in Japan, and in the treatment of senile dementia as well.[1][2] It also appears to be useful in the treatment of glaucoma.[3] Bifemelane acts as a monoamine oxidase inhibitor (MAOI) of both isoenzymes, with competitive (reversible) inhibition of MAO-A (Ki = 4.20 μM) (making it a reversible inhibitor of monoamine oxidase A (RIMA)) and non-competitive (irreversible) inhibition of MAO-B (Ki = 46.0 μM),[4][5][6] and also acts (weakly) as a norepinephrine reuptake inhibitor.[7] The drug has nootropic, neuroprotective, and antidepressant-like effects in animal models, and appears to enhance the cholinergic system in the brain.[8][9][10]

See also

References

Шаблон:Reflist

Шаблон:Antidepressants Шаблон:Antidementia

Шаблон:Adrenergics Шаблон:Dopaminergics Шаблон:Serotonergics

Шаблон:Nervous-system-drug-stub